These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9302366)

  • 1. Clinical activity score as a guide in the management of patients with Graves' orbitopathy.
    Rose GE
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):15. PubMed ID: 9302366
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
    Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte-subsets in endocrine exophthalmos.
    Cenmamo G; Bizzarro A; Castello G
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):43-5. PubMed ID: 3879963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated Graves' ophthalmopathy: case report.
    Exstrum TD; Ramos-Gabatin A; Mueller GL
    Mil Med; 1985 Jan; 150(1):37-9. PubMed ID: 3920557
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves' ophthalmopathy: a retrospective analysis of 90 cases.
    Van Ruyven RL; Van Den Bosch WA; Mulder PG; Eijkenboom WM; Paridaens AD
    Eye (Lond); 2000 Oct; 14 Pt 5():761-4. PubMed ID: 11116700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease).
    Staar S; Müller RP; Hammer M; Nolte M
    Front Radiat Ther Oncol; 1997; 30():206-17. PubMed ID: 9205903
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
    Masiello E; Veronesi G; Gallo D; Premoli P; Bianconi E; Rosetti S; Cusini C; Sabatino J; Ippolito S; Piantanida E; Tanda ML; Chiovato L; Wiersinga WM; Bartalena L
    J Endocrinol Invest; 2018 Dec; 41(12):1425-1432. PubMed ID: 29946800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry.
    Đorić I; Žarković M; Radojičić Z; Repac N; Janićijević A; Rotim K; Tasić G; Rasulić L
    Acta Clin Croat; 2017 Mar; 56(1):21-27. PubMed ID: 29120123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of asymmetric exophthalmos in Graves orbitopathy.
    Soroudi AE; Goldberg RA; McCann JD
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):224-5. PubMed ID: 15167731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initial clinical characteristics of Graves' orbitopathy vary with age and sex.
    Kendler DL; Lippa J; Rootman J
    Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Was Tiepolo's wife affected by Graves' disease?
    Dallari V; Gazzini L; Sacchetto A
    J Endocrinol Invest; 2021 Jul; 44(7):1551-1552. PubMed ID: 33387353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves exophthalmos without muscle involvement.
    Hesse RJ
    Ophthalmology; 1992 May; 99(5):645-6. PubMed ID: 1594204
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
    Gerding MN; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exophthalmos in autoimmune thyroid disease.
    Amino N; Yuasa T; Yabu Y; Miyai K; Kumahara Y
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1232-4. PubMed ID: 6893711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between computed tomography and magnetic resonance imaging in Graves' orbitopathy.
    Nianiaris N; Hurwitz JJ; Chen JC; Wortzman G
    Can J Ophthalmol; 1994 Feb; 29(1):9-12. PubMed ID: 8180879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmological diagnosis in autoimmune orbitopathy.
    Boergen KP
    Exp Clin Endocrinol; 1991 May; 97(2-3):235-42. PubMed ID: 1915640
    [No Abstract]   [Full Text] [Related]  

  • 20. Graves' disease complicating myelopathy.
    Frisbie JH; Fisch B
    Paraplegia; 1992 Aug; 30(8):593-7. PubMed ID: 1523003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.